Investigation of the Reliability and Validity of the Movement Imagination Questionnaire - Revised Second in Acute Stroke Patients

February 23, 2020 updated by: Fatma Nurveren, Hacettepe University

Our study was planned to investigate the reliability validity of the Movement Imagery Questionnaire- RS in acute stroke patients.

For our study, the Turkish version of the Movement Imagery Questionnaire-RS will be established first. Then, the reliability and validity of the questionnaire in acute stroke patients will be examined.

The study included 70 stroke patients hospitalized in the Stroke Unit of the Neurology Department of Hacettepe University Hospitals and individuals between 50-75 years of age who do not have any disease in Ankara.

Study Overview

Status

Unknown

Conditions

Detailed Description

Motor imagery is a cognitive process that the person continues mentally without actually performing a particular motor movement. The concept of motor imaging has become more and more important in recent years and has allowed us to obtain different ideas about the emergence of motor movements. When the literature is analyzed, it was reported that the brain areas activated during the motor movement of individuals overlap with the active areas in the imaging process.As an individual's ability to imagine movement increases, the centers participating in the motor system become so activated. In the literature, it has been stated that this motor imaging ability may decrease in people who have had a stroke. For this reason, the motor imagination ability of the person should be evaluated before a suitable rehabilitation program is decided.When we look at the literature, it was seen that the Movement Imagery Questionnaire - Revised Second was used to evaluate the patients with subacute and chronic stroke, and there was no validity and reliability study in patients with acute stroke. Considering this situation, it was planned to translate the Movement Imagery Questionnaire -RS questionnaire into our language within the scope of our study and then to investigate the reliability and validity of patients with acute stroke.

Study Type

Observational

Enrollment (Anticipated)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 75 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study included 70 stroke patients hospitalized in the Stroke Unit of the Neurology Department of Hacettepe University Hospitals and individuals aged 50-75 years living in Ankara who do not have any disease.

Description

Inclusion Criteria:

Acute Stroke Patients:

  • Ischemic stroke diagnosis by the relevant neurologist,
  • At least 24 hours after stroke,
  • Stroke for the first time
  • Stable vital signs and no improvement in symptoms for 48 hours
  • 50 to 75 years of age
  • 15 points from Glaskow Coma Scale (GCS),
  • Absence of apraxia and aphasia (apraxia and aphasia will be evaluated by the relevant neurologist.)
  • Being able to walk at least 10 m independently
  • A maximum score of 15 from the Beck Depression Inventory
  • To score 24 or more from Mini Mental Test
  • Signing the Informed Volunteer Consent Form

Healthy Group:

  • Being in the 50-75 age range
  • Signing the Informed Volunteer Consent Form
  • A maximum score of 15 from the Beck Depression Inventory
  • Not having a known neurological disease

Exclusion Criteria:

  • Supplement for stroke patients; any neurological, orthopedic, psychological (such as schizophrenia, psychosis) and systemic problems for the healthy group
  • Use of drugs to affect epilepsy, seizure attacks and cognition
  • Cerebellum or mesencephalon lesion
  • The presence of contractures or excessive spasticity in the joints to limit movement
  • Neglect of a body half
  • Irreversible visual (hemianopsia, blindness), presence of auditory disability
  • Participate in another experimental or drug study during the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Healthy Group
  1. Demographic Information
  2. Mental Chronometry Test
  3. Movement Imagination Questionnaire- Revised Second
  4. Beck Depression Inventory
Acute Stroke Patients
  1. Demographic Information
  2. Mental Chronometry Test
  3. Movement Imagination Questionnaire- Revised Second
  4. Beck Depression Inventory
  5. Trail Making Test
  6. Barthel Index
  7. Motor Assessment Scale
  8. Trunk Impairment Scale
  9. Mini Mental Test
  10. Glaskow Coma Scale

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Movement Imagination Questionnaire - Revised Second
Time Frame: about 15 minutes
Movement Imagination Questionnaire - Revised Second is a questionnaire used to evaluate motor imaging ability. The Movement Imagination Questionnaire has been revised especially for use in patients with motor function loss such as stroke. The questionnaire has 7 activities in total. Although most of these activities are sitting, there are also activities that must be done during standing. Each action is questioned both visually and kinesthetically and is scored based on the ease of visualization in the range of 0-7 points. Higher scores mean a better outcome.
about 15 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Motor Assessment Scale
Time Frame: about ten minutes
The Motor Assessment Scale is designed to measure the functional properties of stroke patients. This assessment method evaluates the ability of stroke patients to perform functional tasks. The Motor Assessment Scale consists of eight motor tasks: (1) turning from the supine position, (2) sitting on your back, (3) sitting balance, (4) standing up, (5) walking, (6) upper limb function (7) hand gestures and (8) advanced hand gestures. In addition to these eight engines, the Motor Assessment Scale contains one more item that measures the overall tone. Each item is evaluated on a seven-degree scale from 0 to 6 (optimal motor behavior). The criterion for each degree in the scale corresponds to the description of the activity to be performed. In some cases, the maximum score (6 points) reflects the quality of performance; in others, it corresponds to performance over a period of time.
about ten minutes
Mental Chronometry Test
Time Frame: about one minute
Mental chronometry is an objective method used to evaluate motor imagery. It examines the time difference between actually making a movement and imagining the same movement. In general, in healthy individuals, the imagined movement time and movement time are related, but there are studies showing that this time is impaired in stroke patients. In our study, a 10 m walking test will be used to measure mental chronometry. First of all, the patient will be asked to walk 10 m independently and the time will be recorded. He will then be asked to imagine the movement and stop the stopwatch when he begins to imagine and stop himself again when he ends. Time difference and mental chronometry rate will be calculated.
about one minute
Trail Making Test
Time Frame: about five minutes
Trail Making Test It is used to evaluate individuals' visual scanning speed, managerial functions, visual-motor perception, motor function, planning, organization, abstract thinking and response limitation. The test consists of 2 parts, A and B. In section A, the individual is asked to combine the numbers from 1 to 25 and completion time is recorded. In section B, the individual completes the ordering, corresponding to a number and a letter, respectively, and the completion time is recorded.
about five minutes
Barthel Index
Time Frame: about 5 minutes
Barthel Index evaluates the basic activities of daily life in order to determine at what level individuals can independently determine activities such as nutrition, washing, self-care, dressing, bowel care and bladder care, sitting on the toilet, going from bed to wheelchair, using walking / wheelchair and climbing stairs. It is a 10-item scale. The scale has scoring ranging from 0 to 20 or 0 to 100 depending on the daily life activities.
about 5 minutes
Mental Chronometry Ratio
Time Frame: about one minute
Real performance time - imagery time/ real performance time
about one minute
Trunk Impairment Scale
Time Frame: about one minute
Trunk Impairment Scale is a scale that evaluates post-stroke body disorder. The scale, consisting of 7 parameters, also includes perception of vertical posture, trunk rotation muscle strength and reflexes on the affected and unaffected side, and vertical stop and abdominal manual muscle test sub parameters in Tsuji and colleagues' stroke disorder evaluation set. Each parameter is evaluated over 4 points. The total score ranges from a minimum of 0 to a maximum of 21 points. A higher score means better performance. In this study, only the vertical stop subscale of this scale will be used.
about one minute

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 11, 2019

Primary Completion (ANTICIPATED)

June 1, 2020

Study Completion (ANTICIPATED)

June 1, 2020

Study Registration Dates

First Submitted

February 23, 2020

First Submitted That Met QC Criteria

February 23, 2020

First Posted (ACTUAL)

February 25, 2020

Study Record Updates

Last Update Posted (ACTUAL)

February 25, 2020

Last Update Submitted That Met QC Criteria

February 23, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Stroke

3
Subscribe